Biotech unicorn Ginkgo Bioworks looks to raise over $300M for Series E - Cleantech innovations @ Clixoo
Cleantech Innovations (All Innovations)
Boston | United States
Biotech unicorn Ginkgo Bioworks looks to raise over $300M for Series E
It develops custom microbes for myriad uses, including sustainable agriculture and antibiotic resistance. The company also creates cultured ingredients for perfumes, foods, cannabinoids and cosmetics.
Pitch Book | Last Updated : 16-Sep-19Know more
Related News for